Surgical Robotics Market

Executive Summary

Surgical Robotics Market was valued at US $6.16 billion in 2021 and is projected to grow at 18.39% CAGR over the forecast period to reach US $16.96 billion by 2027. Surgical Robotics Market represented US $1.76 billion opportunity over 2019-2021 and estimated to create US $10.80 billion opportunity in 2027 over 2021.

Surgical Robotics from Consainsights analyses the Surgical Robotics Market in the Life Sciences industry over the forecast period to 2027.

Surgical Robotics research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Surgical Robotics segmentation includes Component, Surgery Type and Geography.

Based on the Component, the Surgical Robotics analysis covers Surgical systems, Accessories, Services.

In Component segment, Surgical systems segment has highest cagr growth of 16.19%.

Based on the Surgery Type, the Surgical Robotics analysis covers Gynecological surgery, Urological surgery, Neurosurgery, Orthopedic surgery, General surgery, Other surgery.

In Surgery Type segment, Gynecological surgery segment has highest cagr growth of 16.19%.

Based on the region, the Surgical Robotics analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Johnson & Johnson, Intuitive Surgical, Inc., KUKA AG, Hansen Medical, Inc., MAKO Surgical Corp., Renishaw plc, THINK Surgical, Inc., Blue Belt Technologies, Inc., Stanmore Implants Worldwide Ltd, Mazor Robotics, Medtech S.A., Zimmer Holdings, Inc., Hansen Medical Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Component

Introduction

In 2021, Surgical systems segment has the highest revenue of US $3.44 billion and is expected to grow at CAGR of 16.19% by 2027 Surgical systems segment has highest cagr growth of 16.19%.

Surgical systems

Surgical systems segment was valued at US $2.46 billion in 2019 and is projected to grow at 16.19% CAGR over the forecast period to reach US $9.48 billion by 2027. Surgical systems segment represented US $0.99 billion opportunity over 2019-2021 and estimated to create US $6.04 billion opportunity in 2027 over 2021.

Accessories

Accessories segment was valued at US $1.90 billion in 2019 and is projected to grow at 16.19% CAGR over the forecast period to reach US $7.35 billion by 2027. Accessories segment represented US $0.76 billion opportunity over 2019-2021 and estimated to create US $4.68 billion opportunity in 2027 over 2021.

Services

Services segment was valued at US $0.03 billion in 2019 and is projected to grow at 16.19% CAGR over the forecast period to reach US $0.12 billion by 2027. Services segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.08 billion opportunity in 2027 over 2021.

Surgery Type

Introduction

In 2021, Gynecological surgery segment has the highest revenue of US $2.49 billion and is expected to grow at CAGR of 16.19% by 2027 Gynecological surgery segment has highest cagr growth of 16.19%.

Gynecological surgery

Gynecological surgery segment was valued at US $1.78 billion in 2019 and is projected to grow at 16.19% CAGR over the forecast period to reach US $6.87 billion by 2027. Gynecological surgery segment represented US $0.71 billion opportunity over 2019-2021 and estimated to create US $4.37 billion opportunity in 2027 over 2021.

Urological surgery

Urological surgery segment was valued at US $1.21 billion in 2019 and is projected to grow at 16.19% CAGR over the forecast period to reach US $4.68 billion by 2027. Urological surgery segment represented US $0.49 billion opportunity over 2019-2021 and estimated to create US $2.98 billion opportunity in 2027 over 2021.

Neurosurgery

Neurosurgery segment was valued at US $0.63 billion in 2019 and is projected to grow at 16.19% CAGR over the forecast period to reach US $2.44 billion by 2027. Neurosurgery segment represented US $0.25 billion opportunity over 2019-2021 and estimated to create US $1.56 billion opportunity in 2027 over 2021.

Orthopedic surgery

Orthopedic surgery segment was valued at US $0.37 billion in 2019 and is projected to grow at 16.19% CAGR over the forecast period to reach US $1.44 billion by 2027. Orthopedic surgery segment represented US $0.15 billion opportunity over 2019-2021 and estimated to create US $0.92 billion opportunity in 2027 over 2021.

General surgery

General surgery segment was valued at US $0.31 billion in 2019 and is projected to grow at 16.19% CAGR over the forecast period to reach US $1.20 billion by 2027. General surgery segment represented US $0.12 billion opportunity over 2019-2021 and estimated to create US $0.76 billion opportunity in 2027 over 2021.

Other surgery

Other surgery segment was valued at US $0.08 billion in 2019 and is projected to grow at 16.19% CAGR over the forecast period to reach US $0.32 billion by 2027. Other surgery segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.21 billion opportunity in 2027 over 2021.